What Is a Millionaire-Maker Stock?
From time to time, investors will run across the term…
Sell
50
XBI Quote, Financials, Valuation and Earnings
Last price:
$76.34
Seasonality move
:
8.5%
Day range:
$75.68 - $79.28
52-week range:
$66.66 - $105.47
Dividend yield:
0.18%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
16.5M
Avg. volume:
14.4M
1-year change:
-12.42%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, SPDR S&P Biotech ETF has -- downside to fair value with a price target of -- per share.
XBI vs. S&P 500
-
Over the past 5 trading days, SPDR S&P Biotech ETF has underperformed the S&P 500 by -5.03% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
SPDR S&P Biotech ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SPDR S&P Biotech ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter SPDR S&P Biotech ETF reported revenues of --.
Earnings Growth
-
SPDR S&P Biotech ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SPDR S&P Biotech ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-05-09 | 2024-05-09 | 2024-05-09 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-05-09 | 2022-05-09 | 2023-05-09 | 2024-05-09 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-05-09 | 2024-05-09 | 2024-05-09 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
XBI
Sector
Market Cap
--
--
Price % of 52-Week High
73.99%
--
Dividend Yield
0.18%
--
Shareholder Yield
--
--
1-Year Price Total Return
-12.42%
--
Beta (5-Year)
0.976
--
Dividend yield:
0.18%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$80.76
200-day SMA
Sell
Level
$92.63
Bollinger Bands (100)
Sell
Level
80.39 - 93.09
Chaikin Money Flow
Buy
Level
465.5M
20-day SMA
Sell
Level
$78.54
Relative Strength Index (RSI14)
Sell
Level
45.16
ADX Line
Sell
Level
23.73
Williams %R
Neutral
Level
-64.7858
50-day SMA
Sell
Level
$81.82
MACD (12, 26)
Sell
Level
-0.32
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
321.2M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, XBI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The XBI average analyst price target in the past 3 months is --.
-
Where Will SPDR S&P Biotech ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that SPDR S&P Biotech ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About SPDR S&P Biotech ETF?
Analysts are divided on their view about SPDR S&P Biotech ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SPDR S&P Biotech ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is SPDR S&P Biotech ETF's Price Target?
The price target for SPDR S&P Biotech ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is XBI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SPDR S&P Biotech ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of XBI?
You can purchase shares of SPDR S&P Biotech ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SPDR S&P Biotech ETF shares.
-
What Is The SPDR S&P Biotech ETF Share Price Today?
SPDR S&P Biotech ETF was last trading at $76.34 per share. This represents the most recent stock quote for SPDR S&P Biotech ETF. Yesterday, SPDR S&P Biotech ETF closed at $78.04 per share.
-
How To Buy SPDR S&P Biotech ETF Stock Online?
In order to purchase SPDR S&P Biotech ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
99
DAVE alert for May 9
Dave [DAVE] is up 9.31% over the past day.
Buy
52
QDEL alert for May 9
QuidelOrtho [QDEL] is down 0.22% over the past day.
Buy
61
TPC alert for May 9
Tutor Perini [TPC] is up 9.61% over the past day.
